Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 2, 2011, Pages 190-197

  Carter Kent, Christine ^a   Brunt, Elizabeth M ^c   Yerian, Lisa M ^b   Alkhouri, Naim ^a   Angulo, Paul ^e   Kohli, Rohit ^d   Ling, Simon C ^f   Xanthakos, Stavra A ^d   Whitington, Peter F ^g   Charatcharoenwitthaya, Phunchai ^e   Yap, Jason ^f   Lopez, Rocio ^b   McCullough, Arthur J ^b   Feldstein, Ariel E ^a  

^a Pediatric Gastroenterology and Nutrition   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

fibrosis; liver biopsy; nonalcoholic fatty liver disease; nonalcoholic fatty liver disease activity score; nonalcoholic steatohepatitis

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; ARTICLE; BODY MASS; CHILD; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; STAIN; STEATOSIS;

ADOLESCENT; BIOPSY; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 79951683409     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181fb47d3     Document Type: Article

References (25)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-31.
2. Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005;43:508-14. (Pubitemid 41111434)
3. Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005;17:636-41. (Pubitemid 41406127)
4. Brunt EM, Tiniakos DG. Pathological features of NASH. Front Biosci 2005;10:1475-84.
5. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44.
6. Day CP, James OF. Steatohepatitis: a tale of two ''hits''? Gastroenter-ology 1998;114:842-5.
7. Chen R, Feldstein AE, McIntyre TM. Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL. J Biol Chem 2009;284:26297-308.
8. Carter-Kent C, Yerian LM, Brunt EM, et al. Nonalcoholic steatohepa-titis in children: a multicenter clinicopathological study. Hepatology 2009;50:1113-20.
9. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepa-tology 2005;41:1313-21. (Pubitemid 40770284)
10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:495-500. (Pubitemid 32164902)
11. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128: 1898-906. (Pubitemid 40824701)
12. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gas-troenterology 2005;129:113-21. (Pubitemid 41002048)
13. Dam-LarsenS, Franzmann M, Andersen IB,etal. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004;53:750-5. (Pubitemid 38561456)
14. McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. Hepatology 2007;45:1343-6. (Pubitemid 46918317)
15. Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:360-9.
16. Li ZZ, Berk M, McIntyre TM, et al. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desa-turase. J Biol Chem 2009;284:5637-44.
17. Chalasani N, Wilson L, Kleiner DE, et al. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 2008;48:829-34.
18. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005;42:641-9. (Pubitemid 41233657)
19. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, et al. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995;127:700-4.
20. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006;44:458-65. (Pubitemid 44214885)
21. Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007;128:837-47. (Pubitemid 350133997)
22. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16. (Pubitemid 32240482)
23. Caldwell SH, Chang CY, Nakamoto RK, et al. Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:595-617. (Pubitemid 39141145)
24. Fromenty B, Robin MA, Igoudjil A, et al. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 2004;30:121-38. (Pubitemid 38715168)
25. Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-90.